Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: May 27, 2024
Open Peer Review Period: May 27, 2024 - Jul 22, 2024
Date Accepted: Sep 2, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Pimenta C, Torres TS, Hoagland B, Cohen M, Gruber Mann C, Jalil CM, Carvalheira E, Freitas L, Fernandez N, Castanheira D, Benedetti M, Moreira J, Simpson K, Trefiglio R, O’Malley G, Veloso VG, Grinsztejn B

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

JMIR Public Health Surveill 2024;10:e60961

DOI: 10.2196/60961

PMID: 39446416

PMCID: 11544328

Preparing for implementation of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis within the Brazilian public health system: results from the formative qualitative phase of the ImPrEP CAB Brasil Study

  • Cristina Pimenta; 
  • Thiago Silva Torres; 
  • Brenda Hoagland; 
  • Mirian Cohen; 
  • Claudio Gruber Mann; 
  • Cristina M. Jalil; 
  • Eduardo Carvalheira; 
  • Lucilene Freitas; 
  • Nilo Fernandez; 
  • Debora Castanheira; 
  • Marcos Benedetti; 
  • Julio Moreira; 
  • Keila Simpson; 
  • Roberta Trefiglio; 
  • Gabrielle O’Malley; 
  • Valdilea G Veloso; 
  • Beatriz Grinsztejn

ABSTRACT

Background:

Although long-acting injectable cabotegravir (CAB-LA) preexposure prophylaxis (PrEP) has proven efficacious for HIV prevention in clinical trials, additional research is needed to guide effective implementation in real world settings. Formative work with community members and health care providers (HCP) is especially important to provide insight to the needs and contexts of specific populations, reveal potential obstacles to service implementation, mitigate barriers and leverage facilitators, increasing the likelihood of achieving the desired outcomes.

Objective:

This article describes our formative work to develop an initial implementation package for CAB-LA for PrEP within the ImPrEP CAB-Brasil study.

Methods:

ImPrEP CAB-Brasil is an implementation study of same-day delivery of CAB-LA PrEP for young sexual and gender minorities (SGM; aged 18-30 years) in six existing oral PrEP public health clinics. We conducted formative research to prepare for the implementation of ImPrEP CAB-Brasil through (1) community mobilization; (2) process mapping; and (3) focus group discussions with young SGM (N=92) and HCP (N=20) to identify initial perceptions of facilitators and barriors for the implementation of CAB-LA PrEP implementation, refine an mHealth tool to support PrEP choice, and evaluate the acceptability of using a text message appointment reminder intervention through WhatsApp.

Results:

A community mobilization team composed of 34 SGM community leaders collaborated in refining a prototype for an mHealth intervention and contributed to the planning of peer education activities. We also engaged with HCP to create three process maps for each site to describe the initial inclusion visit, follow-up visits, and laboratory flow. The main challenge identified for same-day CAB-LA PrEP delivery was the duration of clinic visits due to a high number of laboratory and HIV counseling steps necessary. Proposed solutions included having point-of-care HIV rapid tests (with additional training) instead of laboratory tests and need for additional counseling staff. Identified barriers for CAB-LA PrEP implementation through focus group discussions incorporated the training of HCP, creating a stigma-free environment, and supporting adherence to injection appointments. mHealth educational tool and WhatsApp reminder text messages were highly acceptable by SGM and HCP, indicating their potential to support PrEP choice and adherance. Focus group participants identified stigma against SGM and persons using PrEP as barriers to injecta,ble PrEP implementation. Content analysis on cultural appropriateness of language and overall clarity of the material contributed to the refinement of the mHealth technology.

Conclusions:

Structured formative work with SGM persons and health providers generated important refinements to context-specific materials and plans to launch ImPrEP CAB-Brasil in public health clinics. Ongoing implementation monitoring will use the process maps to identify additional barriers and potential solutions to CAB-LA PrEP same-day delivery. Summative evaluations are needed to measure the effectiveness of the mHealth educational intervention to support PrEP choice and the use of WhatsApp appointment reminders. Clinical Trial: ClinicalTrials.gov NCT05515770 (29-AUG-2022)


 Citation

Please cite as:

Pimenta C, Torres TS, Hoagland B, Cohen M, Gruber Mann C, Jalil CM, Carvalheira E, Freitas L, Fernandez N, Castanheira D, Benedetti M, Moreira J, Simpson K, Trefiglio R, O’Malley G, Veloso VG, Grinsztejn B

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

JMIR Public Health Surveill 2024;10:e60961

DOI: 10.2196/60961

PMID: 39446416

PMCID: 11544328

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.